MDA-231-AdM-1834: Human Breast Adenocarcinoma Cell Line

MDA-231-AdM-1834: Human Breast Adenocarcinoma Cell Line



MDA-231-AdM-1834 is a breast adenocarcinoma cell line established from the MDA231-TGL cell line and is an adrenal gland-selective metastatic derivative.  

This cell line is part of a panel of human breast cancer cell lines selected to metastasize to specific organs. For the complete panel, see (link to SK1041 marketing sheet).   


This cell line was established from a 51-year-old female of Caucasian ethnicity and was derived from a metastatic site of pleural effusion.   

Lead Inventor 

Joan Massagué, PhD, Chief Scientific Officer, Director, Sloan Kettering Institute, and Laboratory Head, Cancer Biology & Genetics Program, MSK 

This cell line is jointly owned with MD Anderson and is available for licensing through an interinstitutional agreement. 

Key References 

  • Minn A et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050) 518-524. (PubMed ID: 16049480

Stage of Development

Ready to use